Faecal Occult Testing Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

Faecal Occult Testing Market Overview

Faecal occult testing plays a crucial role in early screening of gastrointestinal disorders and colorectal cancer risk assessment by identifying hidden traces of blood in stool samples, supporting timely clinical decisions and preventive healthcare strategies. The market reached a value of approximately USD 1.16 Billion in 2025, and is anticipated to witness steady expansion, supported by the rising burden of colorectal cancer, growing recognition of stool-based screening as a non-invasive first-line option, and broadening adoption of high-sensitivity Faecal immunochemical tests across population screening programs. Continued integration with colorectal cancer screening pathways and laboratory automation is reinforcing the role of faecal occult testing across diagnostic workflows globally.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Faecal Occult Testing Market Segmentation

Faecal Occult Testing Market Growth Analysis and Key Influencers

Faecal Occult Testing Market Dynamics

This section analyzes key factors influencing market growth, including disease burden, regulatory drivers, technology adoption, cost dynamics, and ecosystem shifts.

Faecal Occult Testing Market Growth Drivers

Rising Colorectal Cancer Incidence and Screening Guidelines Driving Market Growth

The market is witnessing strong growth driven by the rising incidence of colorectal cancer and broadening guideline-based cancer screening recommendations. According to the American Cancer Society, an estimated 108,860 new cases of colorectal cancer were expected to be diagnosed in the United States in 2026. The US Preventive Services Task Force recommends screening for all average-risk adults aged 45 to 75 years using high-sensitivity guaiac Faecal occult blood testing or annual Faecal immunochemical testing, further demonstrating that faecal immunochemical testing increased early-stage colorectal cancer diagnoses relative to usual care.

Faecal Occult Testing Market Restraints

Limited Sensitivity and Patient Compliance Challenges Limiting Market Penetration

Lower participation in follow-up colonoscopy after positive stool-based screening tests remains a major restraint, limiting the clinical effectiveness of Faecal occult testing programs. Chyke A. Doubeni et al., 2025, highlighted that that inadequate follow-up colonoscopy after positive noninvasive colorectal cancer screening results reduces screening effectiveness and may increase disease burden. Additionally, growing competition from newer stool DNA assays and blood-based screening technologies is intensifying pressure on traditional Faecal occult testing adoption. However, expanding access to at-home screening kits and broader investments in preventive healthcare initiatives continue supporting market penetration during the forecast period.

Faecal Occult Testing Market Opportunities

Increasing At-Home Testing and Molecular Biomarker Integration Boosting the Market Landscape

The growing adoption of at-home colorectal cancer screening solutions is creating significant market opportunities, supported by rising awareness regarding early disease detection and increasing preference for non-invasive diagnostic methods. For instance, in February 2026, Biomerica received approval from Vietnam’s Hanoi Department of Health for nationwide distribution of its EZ Detect at-home colorectal screening test, strengthening access to affordable screening across Southeast Asia. The product’s simplified testing approach and elimination of stool handling are expected to improve patient compliance rates. These developments are reinforcing demand for home-based Faecal occult testing solutions and expanding the adoption of colorectal cancer screening across underserved populations globally.

Faecal Occult Testing Market Trends

Shift from Guaiac to Immunochemical and Molecular Testing Shaping Market Evolution

The growing transition from traditional guaiac-based Faecal occult blood testing to Faecal immunochemical testing and molecular stool DNA platforms is a key trend shaping the market, supported by improved sensitivity, no dietary or medication restrictions, and faster turnaround times. The Cologuard Plus multitarget stool DNA test showed significant superiority over an independent Faecal immunochemical test for overall colorectal cancer sensitivity in the BLUE-C study, while continued automation across colonoscopy referral pathways is reinforcing the role of advanced stool-based screening during the forecast period.

Faecal Occult Testing Market Share

Immuno-FOBAgglutination Test Likely to Dominate the Market Segment by Test Type

The immuno-FOB agglutination test segment is likely to lead the market, supported by its high sensitivity and specificity in detecting low levels of occult blood for early colorectal cancer screening. The segment also benefits from rising awareness regarding preventive diagnostics and increasing adoption of non-invasive testing methods. Continued integration with reflex molecular biomarker confirmation and quality-assured laboratory workflows reinforces the segment's leadership across in vitro diagnostics platforms supporting national screening programs.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Faecal Occult Testing Market Regional Analysis

Among all the regions, North America is anticipated to witness significant growth as it benefits from strong preventive healthcare infrastructure, favorable reimbursement frameworks, and increasing adoption of routine colorectal cancer testing across hospitals and diagnostic laboratories. The rising awareness regarding early disease detection and expanding government-backed screening initiatives further support market growth. Moreover, broader implementation of preventive healthcare services is improving patient participation in screening programs and reinforcing sustained regional market expansion during the forecast period.

Leading Players in the Faecal Occult Testing Market

Key Questions Answered in the Faecal Occult Testing Market Report

• What was the faecal occult testing market value in 2025?
• What is the faecal occult testing market forecast outlook for 2026-2035?
• What major factors aid the demand for the faecal occult testing market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market’s major drivers, opportunities, and restraints?
• What are the major faecal occult testing market trends?
• Which test type is expected to dominate the market segment?
• Which end user is expected to dominate the market segment?
• Who are the key players in the faecal occult testing market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?